Ibrahim Kassas, MD
Interventional Cardiology · Evergreen Park, ILNPI 1629366406
Payments from drug & device makers
Across 240 payments — averaging $72.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$5K
- Abbott$5K
- Boston Scientific$3K
- Medtronic$2K
- Novo Nordisk$287
- Novartis$280
- plus $2K from 26 others
What the payments were for
- Consulting fees$1,2507%
- Travel & lodging$8,65650%
- Food & beverage$7,33442%
- Education$140%
- Entertainment$380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 49 | $4,918 |
| Abbott | 39 | $4,620 |
| Boston Scientific | 22 | $3,141 |
| Medtronic(2 entities) | 20 | $1,864 |
| Novo Nordisk | 9 | $287 |
| Novartis | 19 | $280 |
| Cardiva Medical, Inc. | 9 | $255 |
| Teleflex LLC | 3 | $197 |
| Boehringer Ingelheim | 10 | $191 |
| Inspire Medical Systems, Inc. | 2 | $166 |
| Penumbra, Inc. | 1 | $145 |
| AstraZeneca | 9 | $125 |
| Pfizer | 5 | $117 |
| Atricure, Inc. | 4 | $114 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $113 |
| E.r. Squibb & Sons, L.L.C. | 5 | $100 |
| Heartflow, Inc. | 5 | $100 |
| Abiomed | 1 | $96 |
| Amgen | 3 | $63 |
| Terumo Medical Corporation | 2 | $49 |
| Esperion Therapeutics, Inc. | 2 | $47 |
| Philips North America LLC | 2 | $45 |
| Imperative Care, Inc | 2 | $44 |
| Opsens Inc. | 1 | $38 |
| AbbVie | 1 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $31 |
| Johnson & Johnson | 2 | $30 |
| Shockwave Medical, Inc | 1 | $23 |
| Angiodynamics, Inc. | 1 | $22 |
| Cordis US CORP. | 1 | $16 |
| Jubilant Draximage Inc. | 1 | $14 |
| Cvrx, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$2,932
- Watchman$1,265
- WATCHMAN FLX$1,250
- CoreValve Evolut$1,113
- PASCAL$840
- 3F$240
- Xience V coronary stent system$223
- WATCHMAN Access System$150
- Inspire$147
- Indigo System$145
- Edwards SAPIEN 3 Transcatheter Heart Valve$141
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$135
- MANTA$126
- COREVALVE EVOLUT R$114
How this compares
$17,292 in reported general payments places this provider in the 65th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 123 | $119,831 |
| EntrestoSacubitril/Valsartan | 55 | $63,329 |
| JardianceEmpagliflozin | 28 | $37,593 |
| XareltoRivaroxaban | 23 | $27,153 |
| Metoprolol Succinate | 189 | $2,846 |
| ClopidogrelClopidogrel Bisulfate | 105 | $1,570 |
| Atorvastatin Calcium | 127 | $1,147 |
| Losartan Potassium | 140 | $1,097 |
| Furosemide | 120 | $860 |
| Ezetimibe | 11 | $772 |
| Potassium Chloride | 40 | $650 |
| Amiodarone Hcl | 35 | $569 |
| Carvedilol | 109 | $564 |
| Warfarin Sodium | 48 | $495 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 29 | $434 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $117 | $119,831123 claims |
| NovartisEntresto | $280 | $63,32955 claims |
| Boehringer IngelheimJardiance | $191 | $37,59328 claims |
| Johnson & JohnsonXarelto | $30 | $27,15323 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 303 interventional cardiology providers in Illinois.
Other interventional cardiology in Evergreen Park
- Charles DavidsonChicago$5.8M
- Ravi RamanaPalos Park$2.8M
- Mark RicciardiEvanston$2.2M
- Andrei PopElk Grove Village$1.9M
- Krishna Rocha SinghSpringfield$1.7M
- Bruce LewisMaywood$1.3M
- Justin LevisayEvanston$837K
- Atman ShahChicago$794K
- Laura DavidsonChicago$661K
- Sunil AgarwalSpringfield$609K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.